Sutro Biopharma STRO
NASDAQ STRO
$20.07 -0.47 (-2.29%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sutro Biopharma (STRO) Total Debt (QoQ) (2018 - 2023)

Analysis

Sutro Biopharma (STRO) Total Debt (QoQ) (2018 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Sutro Biopharma 334.33 Mn 169.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -43.10%
Sep 30, 2023 -30.01%
Jun 30, 2023 -23.00%
Mar 31, 2023 -18.62%
Dec 31, 2022 -15.62%
Sep 30, 2022 -13.45%
Jun 30, 2022 -11.81%
Mar 31, 2022 0.59%
Dec 31, 2021 0.60%
Sep 30, 2021 0.58%
Jun 30, 2021 0.56%
Mar 31, 2021 0.55%
Dec 31, 2020 0.55%
Sep 30, 2020 0.54%
Jun 30, 2020 0.52%
Mar 31, 2020 144.58%
Dec 31, 2019 -12.93%
Sep 30, 2019 -11.42%
Jun 30, 2019 -10.23%
Mar 31, 2019 -3.11%